Lone Star Withdraws Effort to Replace Enzo Board Members After ISS Supports Firm's Candidates | GenomeWeb

NEW YORK (GenomeWeb) – Investment firm Lone Star Value Management has withdrawn its proxy contest to replace two members of Enzo Biochem's board of directors after Institutional Shareholder Services backed Enzo's candidates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.